Cathie Wood’s ARK ETFs make major buys in Deere & Co, Exact Sciences stock

Published 15/08/2025, 01:08
Cathie Wood’s ARK ETFs make major buys in Deere & Co, Exact Sciences stock

Cathie Wood’s ARK ETF published their daily trades for Thursday, 14th August 2025, revealing a series of significant stock purchases across various sectors. Topping the list in dollar value was the acquisition of 64,789 shares of DEERE & CO (NYSE:DE) through ARK’s flagship ARKK ETF, amounting to a substantial $33,271,743 investment. This move underscores ARK’s bullish stance on the agriculture and construction equipment manufacturer.

Following closely, ARK’s ARKK ETF also added 298,422 shares of EXACT SCIENCES CORP (NASDAQ:EXAS), a provider of cancer screening and diagnostic tests, with a total dollar value of $13,402,132. This purchase aligns with ARK’s focus on innovative healthcare solutions and marks a continued accumulation, as the fund also bought shares of EXAS in previous days, including a significant buy on the prior Thursday.

The ARKK ETF further diversified its portfolio with the purchase of 80,619 shares of ILLUMINA INC (NASDAQ:ILMN), a leader in genomic sequencing, for $7,914,483. This investment signals ARK’s sustained interest in the genomics space, a key theme across its ETFs.

Among other notable transactions, ARK’s ARKW ETF bought 76,713 shares of DATADOG INC (NASDAQ:DDOG), a monitoring and analytics platform for cloud-scale applications, totaling $9,873,730. Additionally, the same ETF acquired 86,706 shares of BLOCK INC (NYSE:XYZ), a financial services and digital payments company, with a total value of $6,672,026.

ARK’s ARKK ETF also increased its stake in ROBINHOOD MARKETS INC (NASDAQ:HOOD) by purchasing 87,681 shares, valued at $9,523,910. This move comes alongside a smaller purchase of the stock earlier in the week, suggesting a growing interest in the trading platform company.

Smaller yet strategic buys included 114,044 shares of IBOTTA INC (IBTA) split between the ARKW and ARKF ETFs, amounting to $3,863,810, and 133,295 shares of PERSONALIS INC (NASDAQ:PSNL) through the ARKG ETF, valued at $643,814.

Moreover, ARK’s ARKK and ARKG ETFs bought a total of 25,411 shares of GENEDX HOLDINGS CORP (WGS), a diagnostic solutions firm, for $3,128,348, following a pattern of investment in the company observed over the past week.

These trades reflect ARK’s investment strategy, focusing on disruptive innovation and growth potential. Investors and market watchers will be keen to see how these positions develop in the context of ARK’s broader portfolio strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.